In assessing the in vivo beneficial action of PSELT in SHHF animals, we then investigated whether the peptide also mitigates cardiac dysfunction by analyzing the levels of key markers of HF, such as circulating LDH and BNP, and myocardial GAL-3. The gene discussed is LGALS3; the disease is hydrops fetalis.